232 related articles for article (PubMed ID: 18541523)
1. Post-infarct treatment with an erythropoietin-gelatin hydrogel drug delivery system for cardiac repair.
Kobayashi H; Minatoguchi S; Yasuda S; Bao N; Kawamura I; Iwasa M; Yamaki T; Sumi S; Misao Y; Ushikoshi H; Nishigaki K; Takemura G; Fujiwara T; Tabata Y; Fujiwara H
Cardiovasc Res; 2008 Sep; 79(4):611-20. PubMed ID: 18541523
[TBL] [Abstract][Full Text] [Related]
2. Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis.
Kobayashi H; Yasuda S; Bao N; Iwasa M; Kawamura I; Yamada Y; Yamaki T; Sumi S; Ushikoshi H; Nishigaki K; Takemura G; Fujiwara T; Fujiwara H; Minatoguchi S
J Cardiovasc Pharmacol; 2009 Dec; 54(6):510-9. PubMed ID: 19755919
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin in cardioprotection: does it have a future or is it all in the past?
Mehta JL
Cardiovasc Res; 2008 Sep; 79(4):549-50. PubMed ID: 18583337
[No Abstract] [Full Text] [Related]
4. Complementary therapeutic effects of dual delivery of insulin-like growth factor-1 and vascular endothelial growth factor by gelatin microspheres in experimental heart failure.
Cittadini A; Monti MG; Petrillo V; Esposito G; Imparato G; Luciani A; Urciuolo F; Bobbio E; Natale CF; Saccà L; Netti PA
Eur J Heart Fail; 2011 Dec; 13(12):1264-74. PubMed ID: 22045926
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival.
Zaruba MM; Huber BC; Brunner S; Deindl E; David R; Fischer R; Assmann G; Herbach N; Grundmann S; Wanke R; Mueller-Hoecker J; Franz WM
Cardiovasc Res; 2008 Mar; 77(4):722-31. PubMed ID: 18055578
[TBL] [Abstract][Full Text] [Related]
6. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure.
Li Y; Takemura G; Okada H; Miyata S; Maruyama R; Li L; Higuchi M; Minatoguchi S; Fujiwara T; Fujiwara H
Cardiovasc Res; 2006 Sep; 71(4):684-94. PubMed ID: 16828072
[TBL] [Abstract][Full Text] [Related]
7. Alteration in erythropoietin-induced cardioprotective signaling by postinfarct ventricular remodeling.
Miki T; Miura T; Yano T; Takahashi A; Sakamoto J; Tanno M; Kobayashi H; Ikeda Y; Nishihara M; Naitoh K; Ohori K; Shimamoto K
J Pharmacol Exp Ther; 2006 Apr; 317(1):68-75. PubMed ID: 16377761
[TBL] [Abstract][Full Text] [Related]
8. Postinfarct active cardiac-targeted delivery of erythropoietin by liposomes with sialyl Lewis X repairs infarcted myocardium in rabbits.
Yamada Y; Kobayashi H; Iwasa M; Sumi S; Ushikoshi H; Aoyama T; Nishigaki K; Takemura G; Fujiwara T; Fujiwara H; Kiso M; Minatoguchi S
Am J Physiol Heart Circ Physiol; 2013 Apr; 304(8):H1124-33. PubMed ID: 23417861
[TBL] [Abstract][Full Text] [Related]
9. Single high-dose intramyocardial administration of erythropoietin promotes early intracardiac proliferation, proves safety and restores cardiac performance after myocardial infarction in rats.
Gäbel R; Klopsch C; Furlani D; Yerebakan C; Li W; Ugurlucan M; Ma N; Steinhoff G
Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):20-5; discussion 25. PubMed ID: 19380336
[TBL] [Abstract][Full Text] [Related]
10. Impairment of cardioprotective PI3K-Akt signaling by post-infarct ventricular remodeling is compensated by an ERK-mediated pathway.
Miki T; Miura T; Tanno M; Nishihara M; Naitoh K; Sato T; Takahashi A; Shimamoto K
Basic Res Cardiol; 2007 Mar; 102(2):163-70. PubMed ID: 16944359
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis.
Wang Y; Ahmad N; Wani MA; Ashraf M
J Mol Cell Cardiol; 2004 Nov; 37(5):1041-52. PubMed ID: 15522281
[TBL] [Abstract][Full Text] [Related]
12. Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodelling in rats.
Xu X; Wan W; Ji L; Lao S; Powers AS; Zhao W; Erikson JM; Zhang JQ
Cardiovasc Res; 2008 Jun; 78(3):523-32. PubMed ID: 18252761
[TBL] [Abstract][Full Text] [Related]
13. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment.
Minatoguchi S; Takemura G; Chen XH; Wang N; Uno Y; Koda M; Arai M; Misao Y; Lu C; Suzuki K; Goto K; Komada A; Takahashi T; Kosai K; Fujiwara T; Fujiwara H
Circulation; 2004 Jun; 109(21):2572-80. PubMed ID: 15123535
[TBL] [Abstract][Full Text] [Related]
14. Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling.
Yarbrough WM; Mukherjee R; Escobar GP; Mingoia JT; Sample JA; Hendrick JW; Dowdy KB; McLean JE; Lowry AS; O'Neill TP; Spinale FG
Circulation; 2003 Oct; 108(14):1753-9. PubMed ID: 12975256
[TBL] [Abstract][Full Text] [Related]
15. Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction.
Fraccarollo D; Widder JD; Galuppo P; Thum T; Tsikas D; Hoffmann M; Ruetten H; Ertl G; Bauersachs J
Circulation; 2008 Aug; 118(8):818-27. PubMed ID: 18678774
[TBL] [Abstract][Full Text] [Related]
16. Effects of basic fibroblast growth factor microspheres on angiogenesis in ischemic myocardium and cardiac function: analysis with dobutamine cardiovascular magnetic resonance tagging.
Liu Y; Sun L; Huan Y; Zhao H; Deng J
Eur J Cardiothorac Surg; 2006 Jul; 30(1):103-7. PubMed ID: 16730451
[TBL] [Abstract][Full Text] [Related]
17. The inhibition of postinfarct ventricle remodeling without polycythaemia following local sustained intramyocardial delivery of erythropoietin within a supramolecular hydrogel.
Wang T; Jiang XJ; Lin T; Ren S; Li XY; Zhang XZ; Tang QZ
Biomaterials; 2009 Sep; 30(25):4161-7. PubMed ID: 19539990
[TBL] [Abstract][Full Text] [Related]
18. Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats.
Azizi Y; Faghihi M; Imani A; Roghani M; Zekri A; Mobasheri MB; Rastgar T; Moghimian M
Eur J Pharmacol; 2015 Aug; 761():101-8. PubMed ID: 25936512
[TBL] [Abstract][Full Text] [Related]
19. Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties.
Copland IB; Jolicoeur EM; Gillis MA; Cuerquis J; Eliopoulos N; Annabi B; Calderone A; Tanguay JF; Ducharme A; Galipeau J
Cardiovasc Res; 2008 Aug; 79(3):405-15. PubMed ID: 18397963
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone attenuates myocardial fibrosis in rats with chronic pressure overload-induced left ventricular hypertrophy.
Moreira VO; Pereira CA; Silva MO; Felisbino SL; Cicogna AC; Okoshi K; Aragon FF; Padovani CR; Okoshi MP; Castro AV
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):325-30. PubMed ID: 19278522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
